Survival in patients with neuroendocrine tumors of the colon, rectum and small intestine
- 1 October 2022
- journal article
- research article
- Published by Elsevier BV in The American Journal of Surgery
- Vol. 225 (1), 58-65
- https://doi.org/10.1016/j.amjsurg.2022.09.053
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Factors Associated with Lymph Node Metastasis in Radically Resected Rectal Carcinoids: a Systematic Review and Meta-analysisJournal of Gastrointestinal Surgery, 2013
- Prognostic Validity of the American Joint Committee on Cancer Staging Classification for Midgut Neuroendocrine TumorsJournal of Clinical Oncology, 2013
- Trends of Incidence and Survival of Gastrointestinal Neuroendocrine Tumors in the United States: A Seer AnalysisJournal of Cancer, 2012
- Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)Annals of Oncology, 2010
- Rectal carcinoids are on the rise: early detection by screening endoscopyEndoscopy, 2009
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activityEndocrine-Related Cancer, 2008
- Rectal carcinoidsCurrent Opinion in Gastroenterology, 2006
- Updated Population-Based Review of Carcinoid TumorsAnnals of Surgery, 2004
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003